Table 1.
Patient characteristics | Level | RCS (n = 143) | LCS (n = 155) | p-value |
---|---|---|---|---|
Sex, n (%) | Male | 69 (48.3%) | 86 (55.5%) | 0.212a |
Female | 74 (51.7%) | 69 (44.5%) | ||
Age, median (IQR) | 70 (61–70) | 71 (64–78) | 0.116b | |
BMI, median (IQR) | 27 (24–30) | 26 (24–28) | 0.116b | |
ASA grade, n (%) | 1 | 12 (8.4%) | 12 (7.7%) | 0.124a |
2 | 70 (49.0%) | 62 (40.0%) | ||
3 | 59 (41.3%) | 72 (46.5%) | ||
4 | 2 (1.4%) | 9 (5.8%) | ||
Neoadjuvant chemotherapy, n (%) | 10 (7.0%) | 26 (16.8%) | 0.010a | |
Temporary diverting ileostomy, n (%) | 8 (25%) | 27 (40.9%) | 0.002a,c | |
Neoadjuvant combined chemo/radiotherapy, n (%) | 6 (4.2%) | 21 (13.5%) | 0.005a |
aχ2-test
bWilcoxon rank sum test
cIn case of rectal resection